Skip to main content

Table 1 Characteristics of patients for MIMVS and FS

From: Perioperative incidence of ECMO and IABP on 5901 mitral valve surgery procedures

 

All

MIMVS

FS

P value

n = 5901

n = 3389

n = 2512

Male gender

52.5%

45.9%

39.9%

 < 0.001

Age (years)

66 (62–76)

65 (62–78)

69 (67–79)

 < 0.001

Body mass index (kg/m2)

25.8 (22.2–28.8)

26.8 (23.4–29.0)

24.3 (21.7–28.4)

0.191

Arterial hypertension

36.2%

35.3%

36.1%

0.789

Diabetes mellitus

    

 Oral antidiabetic drugs

8.9%

7.2%

5.5%

0.006

 Insulin

2.3%

2.8%

2.6%

0.530

Hypercholesterolaemia

41.2%

42.1%

44.3%

0.009

Renal dysfuntion

1.4%

2.3%

2.1%

0.254

Respiratory or lung disease

2.1%

2.3%

1.9%

0.187

Previous disabling stroke

1.5%

1.5%

1.3%

0.687

History of cancer

1.4%

1.9%

2.5%

0.030

Atrial fibrillation

9.4%

8.3%

11.2%

 < 0.001

Peripheral vascular disease

4.8%

4.3%

4.9%

0.556

Coronary artery disease

9.3%

10.2%

8.4%

 < 0.001

Left ventricular ejection fraction

   

0.347

 LVEF > 50%

93.3%

92.4%

91.4%

 

 LVEF 30–50%

6.0%

7.1%

7.3%

 

 LVEF < 30%

0.7%

0.5%

1.3%

 

Previous surgery

2.3%

1.7%

1.9%

0.211

EuroSCORE II (%)

1.2 (1.1–2.8)

1.4(1.1–2.7)

1.9 (1.3–3.1)

0.387

Urgent procedure

2.6%

2.8%

3.1%

0.338

  1. Median (interquartile range) or percentage. Renal dysfunction: dialysis or creatinine > 2 mg/dl
  2. LVEF, left ventricular ejection fraction; MIMVS, minimally invasive mitral valve surgery; FS, full sternotomy